Feasibility of risk assessment for breast cancer molecular subtypes. McCarthy AM, Ehsan S, Hughes KS, Lehman CD, et al. Breast Cancer Res Treat 2024 Jun 25. doi: 10.1007/s10549-024-07404.

Read + Share

Amedeo Smart

Independent Medical Education

McCarthy AM, Ehsan S, Hughes KS, Lehman CD, et al. Feasibility of risk assessment for breast cancer molecular subtypes. Breast Cancer Res Treat 2024 Jun 25. doi: 10.1007/s10549-024-07404.
PMID: 38916820